PPARgamma agonists as a new class of effective treatment for ulcerative colitis
- PMID: 18798571
- DOI: 10.1002/ibd.20765
PPARgamma agonists as a new class of effective treatment for ulcerative colitis
Comment on
-
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7. Gastroenterology. 2008. PMID: 18325386 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources